A RANDOMISED PHASE III STUDY OF RADIATION DOSES AND FRACTIONATION SCHEDULES FOR NON-LOW RISK DUCTAL CARCINOMA IN SITU OF THE BREASTA RANDOMISED PHASE III STUDY OF RADIATION DOSES AND FRACTIONATION SCHEDULES FOR NON-LOW RISK DUCTAL CARCINOMA IN SITU OF THE BREAST

Grant number: 1099860 | Funding period: 2016 - 2020

Active

Abstract

After surgery to remove ductal carcinoma in situ (DCIS), a pre-invasive form of breast cancer, radiotherapy to the breast decreases the risk of recurrence. The study investigates if a higher radiation dose to the tumour bed improves tumour control, and if a shorter course of radiotherapy is as effective as the standard longer course. It also assesses quality of life consequences of treatment and tests biomarkers that may predict the risk of recurrence in individual patients.